Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
Status:
Recruiting
Trial end date:
2024-06-20
Target enrollment:
Participant gender:
Summary
This prospective，multi-center，open-label, controlled study will evaluate the efficacy and
safety of targeted drug in combination with CHOP in treatment of newly diagnosed peripheral
T-cell lymphoma.